Literature DB >> 2245182

Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.

M Heikinheimo1, J Rajantie, P Kuusela, M J Kallio, M A Siimes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2245182      PMCID： PMC1971508          DOI： 10.1038/bjc.1990.396

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

1.  Human fibroblasts produce "pregnancy-specific" beta-1 glycoprotein in vitro.

Authors:  S W Rosen; J Kaminska; I S Calvert; S A Aaronson
Journal:  Am J Obstet Gynecol       Date:  1979-08-01       Impact factor: 8.661

2.  Studies of carcino-fetal proteins. 3. Development of a radioimmunoassay for -fetoprotein. Demonstration of -fetoprotein in serum of healthy human adults.

Authors:  E Ruoslahti; M Seppälä
Journal:  Int J Cancer       Date:  1971-11-15       Impact factor: 7.396

3.  Colorectal carcinoma antigens detected by hybridoma antibodies.

Authors:  H Koprowski; Z Steplewski; K Mitchell; M Herlyn; D Herlyn; P Fuhrer
Journal:  Somatic Cell Genet       Date:  1979-11

4.  Oncoplacental protein SP1--a constitutive and inducible late differentiation marker of the human myelomonocytic lineage.

Authors:  M Heikinheimo; C G Gahmberg; H Bohn; L C Andersson
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

5.  Cholesterol and its precursors in human milk during prolonged exclusive breast-feeding.

Authors:  M J Kallio; M A Siimes; J Perheentupa; L Salmenperä; T A Miettinen
Journal:  Am J Clin Nutr       Date:  1989-10       Impact factor: 7.045

6.  Molecular cloning of a cDNA for human pregnancy-specific beta 1-glycoprotein:homology with human carcinoembryonic antigen and related proteins.

Authors:  B C Rooney; C H Horne; N Hardman
Journal:  Gene       Date:  1988-11-30       Impact factor: 3.688

7.  Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma.

Authors:  M Herlyn; H F Sears; Z Steplewski; H Koprowski
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

8.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Authors:  R C Bast; T L Klug; E St John; E Jenison; J M Niloff; H Lazarus; R S Berkowitz; T Leavitt; C T Griffiths; L Parker; V R Zurawski; R C Knapp
Journal:  N Engl J Med       Date:  1983-10-13       Impact factor: 91.245

9.  Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy.

Authors:  H Halila; U H Stenman; M Seppälä
Journal:  Cancer       Date:  1986-04-01       Impact factor: 6.860

10.  Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.

Authors:  C Haglund; P J Roberts; P Kuusela; T M Scheinin; O Mäkelä; H Jalanko
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640
View more
  1 in total

1.  Factors associated with serum CA19-9 levels among healthy children: a cross-sectional study.

Authors:  Sayo Kawai; Nobuyuki Hamajima; Sueli M Oba-Shinjo; Lucy S Ito; Miyuki Uno; Suely K N Marie
Journal:  BMC Clin Pathol       Date:  2012-12-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.